Challenges and opportunities for improving the landscape for Lewy body dementia clinical trials

Lewy body dementia (LBD), including dementia with Lewy bodies and Parkinson’s disease dementia, affects over a million people in the USA and has a substantial impact on patients, caregivers, and society. Symptomatic treatments for LBD, which can include cognitive, neuropsychiatric, autonomic, sleep,...

Descripción completa

Detalles Bibliográficos
Autores principales: Goldman, Jennifer G., Forsberg, Leah K., Boeve, Bradley F., Armstrong, Melissa J., Irwin, David J., Ferman, Tanis J., Galasko, Doug, Galvin, James E., Kaufer, Daniel, Leverenz, James, Lippa, Carol F., Marder, Karen, Abler, Victor, Biglan, Kevin, Irizarry, Michael, Keller, Bill, Munsie, Leanne, Nakagawa, Masaki, Taylor, Angela, Graham, Todd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7597002/
https://www.ncbi.nlm.nih.gov/pubmed/33121510
http://dx.doi.org/10.1186/s13195-020-00703-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7597002/
https://www.ncbi.nlm.nih.gov/pubmed/33121510
http://dx.doi.org/10.1186/s13195-020-00703-5

Ejemplares similares